Lung Neoplasms: all 7,334 studies

Page 19 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.

• AST-VAC2 Vaccine in Patients With Non-small Cell Lung CancerCompletedNCT03371485Phase 1Results posted
• Comparison of Efficacy and Safety of Tislelizumab (BGB-A317) Versus Docetaxel as Treatment in the Second- or Third-line Setting in Participants With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT03358875Phase 3Results posted
• A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC)CompletedNCT03353675Phase 2Results posted
• Feasibility of an Activity Regimen in Patients With Advanced Stage Lung CancerCompletedNCT03352245Not applicableResults posted
• Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung CancerTerminatedNCT03348904Phase 3Results posted
• Project HERO: Health Empowerment & Recovery OutcomesCompletedNCT03345563Not applicableResults posted
• Safety of PDT-Photofrin® Prior to Lung SurgeryCompletedNCT03344861Phase 1Results posted
• Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung CancerCompletedNCT03337399Not applicableResults posted
• CAR-T Cell Immunotherapy for Advanced Lung CancerTerminatedNCT03330834Phase 1Results posted
• A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung CancerCompletedNCT03329911Phase 3Results posted
• Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT03325816Phase 1/2Results posted
• A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)CompletedNCT03322566Phase 2Results posted
• Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)CompletedNCT03322540Phase 2Results posted
• MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung CancerActive, not recruitingNCT03300817Phase 1Results posted
• Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene MutationsCompletedNCT03299088Phase 1Results posted
• A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)CompletedNCT03296163Phase 3Results posted
• Pembrolizumab in Elderly Patients With Advanced Lung CancerCompletedNCT03293680Phase 2Results posted
• A Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung CancerTerminatedNCT03292133Phase 2Results posted
• Pembrolizumab + Idelalisib for Lung Cancer StudyTerminatedNCT03257722Phase 1/2Results posted
• Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLCCompletedNCT03256136Phase 2Results posted
• DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung CancerTerminatedNCT03255083Phase 1Results posted
• Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted AgentsCompletedNCT03242915Phase 2Results posted
• A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With OsimertinibCompletedNCT03239340Phase 2Results posted
• Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal CarcinomasTerminatedNCT03233724Phase 1/2Results posted
• Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung CancerTerminatedNCT03232892Phase 2Results posted
• Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former SmokersCompletedNCT03232138Phase 2Results posted
• Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or LymphomaCompletedNCT03229278Phase 1Results posted
• Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung CancerTerminatedNCT03228186Phase 2Results posted
• Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.CompletedNCT03220230Results posted
• Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung CancerCompletedNCT03217071Phase 2Results posted
• Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung CancerCompletedNCT03215810Phase 1Results posted
• Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung CancerCompletedNCT03197467Phase 2Results posted
• A Study of Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Second-Line Nivolumab Monotherapy in AsiaCompletedNCT03195491Phase 3Results posted
• A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet ChemotherapyCompletedNCT03191786Phase 3Results posted
• Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLCCompletedNCT03164772Phase 1/2Results posted
• A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Active, not recruitingNCT03157128Phase 1/2Results posted
• Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the LungCompletedNCT03157089Phase 2Results posted
• Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerCompletedNCT03154190Not applicableResults posted
• A Study Comparing the Efficacy and Safety Between IBI308 and Docetaxel in Patients With Advanced or Metastatic NSCLCCompletedNCT03150875Phase 3Results posted
• Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLCActive, not recruitingNCT03141359Phase 2Results posted
• Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT03132532Phase 2Results posted
• A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid CancerTerminatedNCT03131206Phase 1/2Results posted
• QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing CancerTerminatedNCT03127098Phase 1/2Results posted
• CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With NivolumabCompletedNCT03123783Phase 1/2Results posted
• Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer (TASUKI-52)CompletedNCT03117049Phase 3Results posted
• Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung CancerCompletedNCT03098030Phase 2/3Results posted
• Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)TerminatedNCT03095612Phase 1/2Results posted
• Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung OriginCompletedNCT03095274Phase 2Results posted
• Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT03090737Phase 2Results posted
• Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung CancerCompletedNCT03089125Not applicableResults posted
• Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung CancerCompletedNCT03088930Phase 2Results posted
• Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung CancerCompletedNCT03088813Phase 3Results posted
• Trial of Consolidation Pembrolizumab After Concurrent Chemotherapy and Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung CancerCompletedNCT03087760Phase 2Results posted
• Phase II Trial of Continuation Therapy in Advanced NSCLCCompletedNCT03083808Phase 2Results posted
• Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer PatientsCompletedNCT03081689Phase 2Results posted
• A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to ErlotinibCompletedNCT03076164Phase 1/2Results posted
• Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized TrialActive, not recruitingNCT03075072Not applicableResults posted
• Gain-framed Messages and NRT for Lung Cancer Screening PatientsCompletedNCT03069924Phase 2Results posted
• A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)CompletedNCT03066778Phase 3Results posted
• Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)CompletedNCT03061812Phase 3Results posted
• Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryStatus unknownNCT03048500Phase 2Results posted
• Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung CancerCompletedNCT03043599Phase 1/2Results posted
• Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 InhibitorTerminatedNCT03041181Phase 2Results posted
• Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsCompletedNCT03037385Phase 1/2Results posted
• Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung CancerCompletedNCT03035890Not applicableResults posted
• A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)TerminatedNCT03033511Phase 3Results posted
• A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung CancerTerminatedNCT03026166Phase 1/2Results posted
• Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line TherapyCompletedNCT03017885Results posted
• A Stepped Care Intervention to Reduce Disparities in Mental Health Services Among Cancer Patients and CaregiversCompletedNCT03016403Not applicableResults posted
• Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT03014648Phase 2Results posted
• Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase IICompletedNCT03007953Not applicableResults posted
• SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLCCompletedNCT03004183Phase 2Results posted
• An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)CompletedNCT03001882Phase 2Results posted
• A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLCStatus unknownNCT02981108Phase 1/2Results posted
• Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain MetastasesActive, not recruitingNCT02971501Phase 2Results posted
• Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.CompletedNCT02968979Results posted
• A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung CancerTerminatedNCT02967133Phase 2Results posted
• Engagement of Patients With Advanced CancerCompletedNCT02966509Not applicableResults posted
• Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung CancerCompletedNCT02965378Phase 2/3Results posted
• Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung CancerTerminatedNCT02963610Phase 1/2Results posted
• Pembrolizumab vs Topotecan in Patients With Small Cell Lung CancerTerminatedNCT02963090Phase 2Results posted
• Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR MutationsTerminatedNCT02954523Phase 1/2Results posted
• Application of 3D Printing Technique in Small Pulmonary Nodule LocalizationCompletedNCT02952261Not applicableResults posted
• Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic MutationsTerminatedNCT02949843Phase 2Results posted
• A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung CancerCompletedNCT02937818Phase 2Results posted
• PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung CancersCompletedNCT02936323Phase 1/2Results posted
• Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC)TerminatedNCT02934503Phase 2Results posted
• A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)CompletedNCT02927301Phase 2Results posted
• Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker MatchesTerminatedNCT02926638Phase 2/3Results posted
• Merestinib In Non-Small Cell Lung Cancer And Solid TumorsTerminatedNCT02920996Phase 2Results posted
• TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Lung Carcinoma (UF-STO-LUNG-003)CompletedNCT02920476Phase 2Results posted
• Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With AtezolizumabTerminatedNCT02919449Phase 1Results posted
• Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung CancerCompletedNCT02916745Phase 1Results posted
• Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid TumorsCompletedNCT02903914Phase 1Results posted
• Incorporating Veterans' Preferences Into Lung Cancer Screening DecisionsCompletedNCT02899754Not applicableResults posted
• Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung CancerCompletedNCT02898116Phase 1/2Results posted
• Pulmonary Rehabilitation Before Lung Cancer ResectionTerminatedNCT02887521Phase 3Results posted
• Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung CancerCompletedNCT02879994Phase 2Results posted
• A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer PatientsCompletedNCT02879617Phase 2Results posted
• OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung NodulesCompletedNCT02872701Phase 2Results posted

← Lung Neoplasms overview